Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Genome-wide association study of bipolar disorder in european american and african american individuals

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Smith, E. N.
  • Bloss, C. S.
  • Badner, J. A.
  • Barrett, T.
  • Belmonte, P. L.
  • Berrettini, W.
  • Byerley, W.
  • Coryell, W.
  • Craig, D.
  • Edenberg, H. J.
  • Eskin, E.
  • Foroud, T.
  • Gershon, E.
  • Greenwood, T. A.
  • Hipolito, M.
  • Koller, D. L.
  • Lawson, W. B.
  • Liu, C.
  • Lohoff, F.
  • McInnis, M. G.
  • McMahon, F. J.
  • Mirel, D. B.
  • Murray, Sarah
  • Nievergelt, C.
  • Nurnberger, J.
  • Nwulia, E. A.
  • Paschall, J.
  • Potash, J. B.
  • Rice, John
  • Schulze, T. G.
  • Scheftner, W.
  • Panganiban, C.
  • Zaitlen, N.
  • Zandi, P. P.
  • Zollner, S.
  • Schork, Nicholas
  • Kelsoe, J. R.

publication date

  • August 2009

journal

  • Molecular Psychiatry  Journal

abstract

  • To identify bipolar disorder (BD) genetic susceptibility factors, we conducted two genome-wide association (GWA) studies: one involving a sample of individuals of European ancestry (EA; n=1001 cases; n=1033 controls), and one involving a sample of individuals of African ancestry (AA; n=345 cases; n=670 controls). For the EA sample, single-nucleotide polymorphisms (SNPs) with the strongest statistical evidence for association included rs5907577 in an intergenic region at Xq27.1 (P=1.6 x 10(-6)) and rs10193871 in NAP5 at 2q21.2 (P=9.8 x 10(-6)). For the AA sample, SNPs with the strongest statistical evidence for association included rs2111504 in DPY19L3 at 19q13.11 (P=1.5 x 10(-6)) and rs2769605 in NTRK2 at 9q21.33 (P=4.5 x 10(-5)). We also investigated whether we could provide support for three regions previously associated with BD, and we showed that the ANK3 region replicates in our sample, along with some support for C15Orf53; other evidence implicates BD candidate genes such as SLITRK2. We also tested the hypothesis that BD susceptibility variants exhibit genetic background-dependent effects. SNPs with the strongest statistical evidence for genetic background effects included rs11208285 in ROR1 at 1p31.3 (P=1.4 x 10(-6)), rs4657247 in RGS5 at 1q23.3 (P=4.1 x 10(-6)), and rs7078071 in BTBD16 at 10q26.13 (P=4.5 x 10(-6)). This study is the first to conduct GWA of BD in individuals of AA and suggests that genetic variations that contribute to BD may vary as a function of ancestry.

subject areas

  • Adolescent
  • Adult
  • African Americans
  • Bipolar Disorder
  • Case-Control Studies
  • Cohort Studies
  • European Continental Ancestry Group
  • Female
  • Genetic Predisposition to Disease
  • Genome, Human
  • Genome-Wide Association Study
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Reference Values
  • Young Adult
scroll to property group menus

Research

keywords

  • ANK3
  • Bipolar Genome Study
  • GAIN
  • allelic heterogeneity
  • genetic background
scroll to property group menus

Identity

PubMed Central ID

  • PMC3035981

International Standard Serial Number (ISSN)

  • 1359-4184

Digital Object Identifier (DOI)

  • 10.1038/mp.2009.43

PubMed ID

  • 19488044
scroll to property group menus

Additional Document Info

start page

  • 755

end page

  • 763

volume

  • 14

issue

  • 8

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support